Literature DB >> 303464

Perinatal addiction: outcome and management.

J F Connaughton, D Reeser, J Schut, L P Finnegan.   

Abstract

The care of the pregnant drug-dependent woman and her newborn infant has become a major and controversial health problem requiring specific approaches to this high-risk mother and neonate. A comprehensive approach to the care of 278 pregnant drug-dependent women and their infants at the Philadelphia General Hospital has significantly reduced maternal and infant morbidity heretofore associated with pregnancies complicated by opiate addiction. Most significantly, the incidence of low birth weight has been reduced to below 20 per cent, and a decrease in severe withdrawal in infants born to mothers in the comprehensive care program has occurred. We propose that application of this approach to women whose pregnancies are complicated by drug dependency is a significant factor in successful management.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303464     DOI: 10.1016/0002-9378(77)90652-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Scientific foundation of clinical practice: opiate use in pregnant women.

Authors:  L P Finnegan; T Hagan; K A Kaltenbach
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

Review 3.  Care of the pregnant patient with medical illness.

Authors:  J L Carson; D L Elliot
Journal:  J Gen Intern Med       Date:  1988 Nov-Dec       Impact factor: 5.128

4.  Buprenorphine: a (relatively) new treatment for opioid dependence.

Authors:  Christopher Welsh; Adela Valadez-Meltzer
Journal:  Psychiatry (Edgmont)       Date:  2005-12

5.  The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations.

Authors:  Hendrée E Jones; Lauren M Jansson; Kevin E O'Grady; Karol Kaltenbach
Journal:  Neurotoxicol Teratol       Date:  2013 Sep-Oct       Impact factor: 3.763

6.  Heroin addiction and pregnancy.

Authors:  R A Bashore; J S Ketchum; K J Staisch; C T Barrett; E G Zimmermann
Journal:  West J Med       Date:  1981-06

Review 7.  Evaluation and management of opioid dependence in pregnancy.

Authors:  Eliza M Park; Samantha Meltzer-Brody; Joji Suzuki
Journal:  Psychosomatics       Date:  2012-08-14       Impact factor: 2.386

8.  Comparison of characteristics of opioid-using pregnant women in rural and urban settings.

Authors:  Sarah H Heil; Stacey C Sigmon; Hendree E Jones; Michael Wagner
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

9.  Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience.

Authors:  Mirjana Vucinovic; Damir Roje; Zoran Vucinovic; Vesna Capkun; Marija Bucat; Ivo Banovic
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.